Growth Metrics

Armata Pharmaceuticals (ARMP) Depreciation & Amortization (CF) (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $212000.0 as the latest value for Q4 2018.

  • Quarterly Depreciation & Amortization (CF) rose 140.91% to $212000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2018, up 202.62% year-over-year, with the annual reading at $1.5 million for FY2025, 13.21% up from the prior year.
  • Depreciation & Amortization (CF) hit $212000.0 in Q4 2018 for Armata Pharmaceuticals, down from $336000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $401000.0 in Q2 2018 to a low of -$27000.0 in Q3 2014.
  • Historically, Depreciation & Amortization (CF) has averaged $107250.0 across 5 years, with a median of $85000.0 in 2016.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 228.57% in 2014 and later surged 470.37% in 2015.
  • Year by year, Depreciation & Amortization (CF) stood at $68000.0 in 2014, then increased by 20.59% to $82000.0 in 2015, then rose by 13.41% to $93000.0 in 2016, then decreased by 5.38% to $88000.0 in 2017, then skyrocketed by 140.91% to $212000.0 in 2018.
  • Business Quant data shows Depreciation & Amortization (CF) for ARMP at $212000.0 in Q4 2018, $336000.0 in Q3 2018, and $401000.0 in Q2 2018.